Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5.17M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1.23M
-
Shares change
-
-8.17M
-
Total reported value, excl. options
-
$11.5M
-
Value change
-
-$85.9M
-
Number of buys
-
3
-
Number of sells
-
-35
-
Price
-
$10.68
Significant Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q1 2023
46 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q1 2023.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.23M shares
of 5.17M outstanding shares and own 23.79% of the company stock.
Largest 10 shareholders include METEORA CAPITAL, LLC (205K shares), CANTOR FITZGERALD, L. P. (155K shares), Periscope Capital Inc. (149K shares), Mint Tower Capital Management B.V. (141K shares), Polar Asset Management Partners Inc. (120K shares), KIM, LLC (100K shares), Shaolin Capital Management LLC (97K shares), AQR Arbitrage LLC (80K shares), BOOTHBAY FUND MANAGEMENT, LLC (49.6K shares), and Walleye Capital LLC (47.9K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.